These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18391133)

  • 21. Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study.
    Ricca V; Mannucci E; Mezzani B; Moretti S; Di Bernardo M; Bertelli M; Rotella CM; Faravelli C
    Psychother Psychosom; 2001; 70(6):298-306. PubMed ID: 11598429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trajectories of Symptom Change in the Treatment for Adolescents With Depression Study.
    Scott K; Lewis CC; Marti CN
    J Am Acad Child Adolesc Psychiatry; 2019 Mar; 58(3):319-328. PubMed ID: 30768414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial.
    Goodyer IM; Reynolds S; Barrett B; Byford S; Dubicka B; Hill J; Holland F; Kelvin R; Midgley N; Roberts C; Senior R; Target M; Widmer B; Wilkinson P; Fonagy P
    Health Technol Assess; 2017 Mar; 21(12):1-94. PubMed ID: 28394249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential treatment with fluoxetine and relapse--prevention CBT to improve outcomes in pediatric depression.
    Kennard BD; Emslie GJ; Mayes TL; Nakonezny PA; Jones JM; Foxwell AA; King J
    Am J Psychiatry; 2014 Oct; 171(10):1083-90. PubMed ID: 24935082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR; Clark LA; Thase ME; Jarrett RB
    J Consult Clin Psychol; 2014 Dec; 82(6):1049-59. PubMed ID: 25045908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
    Cornelius JR; Bukstein OG; Douaihy AB; Clark DB; Chung TA; Daley DC; Wood DS; Brown SJ
    Drug Alcohol Depend; 2010 Nov; 112(1-2):39-45. PubMed ID: 20576364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery and recurrence following treatment for adolescent major depression.
    Curry J; Silva S; Rohde P; Ginsburg G; Kratochvil C; Simons A; Kirchner J; May D; Kennard B; Mayes T; Feeny N; Albano AM; Lavanier S; Reinecke M; Jacobs R; Becker-Weidman E; Weller E; Emslie G; Walkup J; Kastelic E; Burns B; Wells K; March J
    Arch Gen Psychiatry; 2011 Mar; 68(3):263-9. PubMed ID: 21041606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).
    Piacentini J; Bennett S; Compton SN; Kendall PC; Birmaher B; Albano AM; March J; Sherrill J; Sakolsky D; Ginsburg G; Rynn M; Bergman RL; Gosch E; Waslick B; Iyengar S; McCracken J; Walkup J
    J Am Acad Child Adolesc Psychiatry; 2014 Mar; 53(3):297-310. PubMed ID: 24565357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined cognitive-behavioural therapy and pharmacotherapy for adolescent depression: Does it improve outcomes compared with monotherapy?
    Vitiello B
    CNS Drugs; 2009; 23(4):271-80. PubMed ID: 19374457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onset of alcohol or substance use disorders following treatment for adolescent depression.
    Curry J; Silva S; Rohde P; Ginsburg G; Kennard B; Kratochvil C; Simons A; Kirchner J; May D; Mayes T; Feeny N; Albano AM; Lavanier S; Reinecke M; Jacobs R; Becker-Weidman E; Weller E; Emslie G; Walkup J; Kastelic E; Burns B; Wells K; March J
    J Consult Clin Psychol; 2012 Apr; 80(2):299-312. PubMed ID: 22250853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.
    Jarrett RB; Minhajuddin A; Gershenfeld H; Friedman ES; Thase ME
    JAMA Psychiatry; 2013 Nov; 70(11):1152-60. PubMed ID: 24005123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
    Lam RW; Levitt AJ; Levitan RD; Michalak EE; Cheung AH; Morehouse R; Ramasubbu R; Yatham LN; Tam EM
    JAMA Psychiatry; 2016 Jan; 73(1):56-63. PubMed ID: 26580307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.
    Perlis RH; Nierenberg AA; Alpert JE; Pava J; Matthews JD; Buchin J; Sickinger AH; Fava M
    J Clin Psychopharmacol; 2002 Oct; 22(5):474-80. PubMed ID: 12352270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial.
    DeRubeis RJ; Zajecka J; Shelton RC; Amsterdam JD; Fawcett J; Xu C; Young PR; Gallop R; Hollon SD
    JAMA Psychiatry; 2020 Mar; 77(3):237-245. PubMed ID: 31799993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents.
    Cornelius JR; Douaihy A; Bukstein OG; Daley DC; Wood SD; Kelly TM; Salloum IM
    Addict Behav; 2011 Aug; 36(8):843-8. PubMed ID: 21530092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.
    Riggs PD; Mikulich-Gilbertson SK; Davies RD; Lohman M; Klein C; Stover SK
    Arch Pediatr Adolesc Med; 2007 Nov; 161(11):1026-34. PubMed ID: 17984403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).
    Vitiello B; Rohde P; Silva S; Wells K; Casat C; Waslick B; Simons A; Reinecke M; Weller E; Kratochvil C; Walkup J; Pathak S; Robins M; March J;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1419-26. PubMed ID: 17135987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.
    ; March J; Silva S; Curry J; Wells K; Fairbank J; Burns B; Domino M; Vitiello B; Severe J; Riedal K; Goldman M; Feeny N; Findling R; Stull S; Baab S; Weller EB; Robbins M; Weller RA; Jessani N; Waslick B; Sweeney M; Dublin R; Walkup J; Ginsburg G; Kastelic E; Koo H; Kratochvil C; May D; LaGrone R; Vaughan B; Albano AM; Hirsch GS; Podniesinki E; Chu A; Reincecke M; Leventhal B; Rogers G; Jacobs R; Pathak S; Wells J; Lavanier SA; Danielyan A; Rohde P; Simons A; Grimm J; Frank S; Emslie G; Kennard B; Hughes C; Mayes TL; Rosenberg D; Benazon N; Butkus M; Bartoi M
    Am J Psychiatry; 2009 Oct; 166(10):1141-9. PubMed ID: 19723787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial.
    Bondar J; Caye A; Chekroud AM; Kieling C
    Lancet Psychiatry; 2020 Apr; 7(4):337-343. PubMed ID: 32199509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating depression and oppositional behavior in adolescents.
    Jacobs RH; Becker-Weidman EG; Reinecke MA; Jordan N; Silva SG; Rohde P; March JS
    J Clin Child Adolesc Psychol; 2010; 39(4):559-67. PubMed ID: 20589566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.